Loxapine Market

Loxapine is a typical antipsychotic medication used primarily in the treatment of schizophrenia. The drug is a member of the dibenzoxazepine class and structurally related to clozapine.
Loxapine Market contains market size and forecasts of Loxapine in global, including the following market information:
Global Loxapine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Loxapine Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Loxapine companies in 2021 (%)
The global Loxapine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Powder Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Loxapine include Watson Laboratories, Teva, Mylan Pharmaceuticals, Grupo Ferrer Internacional, AOP Orphan Pharmaceuticals, Bago Pharmaceutical, Bioprojet Pharma, Galen Pharmaceuticals and Eisai, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Loxapine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Loxapine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Loxapine Market Segment Percentages, by Type, 2021 (%)
Powder
Tablet
Global Loxapine Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Loxapine Market Segment Percentages, by Application, 2021 (%)
Hospital
Drug Store
Global Loxapine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Loxapine Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Loxapine revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Loxapine revenues share in global market, 2021 (%)
Key companies Loxapine sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Loxapine sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Watson Laboratories
Teva
Mylan Pharmaceuticals
Grupo Ferrer Internacional
AOP Orphan Pharmaceuticals
Bago Pharmaceutical
Bioprojet Pharma
Galen Pharmaceuticals
Eisai
Wyeth
Delta Pharma
Swiss Pharmaceutical
Pfizer
Novartis